Latest round

Angel

Last raised

Jul 2021

Total raised

$1.5M

Investors

1

About ChomiX

Based in Nanjing, China, and established in 2021, ChomiX is an biopharmaceutical company that focuses on R&D of proteomics used in the fields of drug target identification, protein target discovery and covalent drug lead compound screening. The company integrated chemical, biological and medical research. As for the team, the chief scientist of the company is Prof. Zijian Guo from Nanjing University, and seven Chinese scholars in the field of chemical biology are gathered, focusing on the field of chemical proteomics. The company's business can be divided into chemical proteomics technical service platform, protein marking technology service platform, kit products, and drug compound screening. The chemical proteomics technical service platform can solve post-translational modification of protein analysis, drug target identification, and metabolite binding protein analysis, and etc. The protein marking technology service platform can directly label non-modified antibodies. The kits includes Amino acid residue-specific labeled probe, post-translational modification specific labeled probe bifunctional corsslinking agent, non-natural chemical reporter probe, and small molecule fluorescent probe.

Who invested in ChomiX

1 investor across 1 round

See all investors in ChomiX

Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.

Funding rounds

  1. Angel

    Jul 5, 2021

    Amount

    $1.5M

    Investors

    Locked

Questions about ChomiX

Who invested in ChomiX?

ChomiX has 1 investor on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.

How much funding has ChomiX raised?

ChomiX has raised 1 venture round. Sign up free to see how much each round raised and the total.

When did ChomiX last raise money?

ChomiX's most recent round on record is a Angel, in Jul 2021.

What does ChomiX do?

Based in Nanjing, China, and established in 2021, ChomiX is an biopharmaceutical company that focuses on R&D of proteomics used in the fields of drug target identification, protein target discovery and covalent drug lead compound screening.

Where is ChomiX headquartered?

ChomiX is headquartered in Nanjing, China.

Which VCs invest in companies like ChomiX?

Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Peak XV Partners, MPCi and Luminous Ventures back biotechnology companies at ChomiX's stage. Their profiles are linked below.

Raising like ChomiX? Find the right VCs.

Capital Atlas matches your startup to active investors by stage, sector and region.

Free to start. Upgrade when you're ready to reach out.